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The brucellae are the etiological agents of brucellosis, a worldwide-distributed zoonosis. These 41 
bacteria are facultative intracellular parasites, and thus are able to adjust their metabolism to the 42 
extra and intracellular environments encountered during an infectious cycle. However, this 43 
aspect of Brucella biology is imperfectly known and the nutrients available in the intracellular 44 
niche are unknown. Here, we investigated the central pathways of C metabolism used by 45 
Brucella abortus by deleting the putative fructose-1,6-bisphosphatases (fbp and glpX), 46 
phosphoenolpyruvate carboxykinase (pckA), pyruvate phosphate dikinase (ppdK) and malic 47 
enzyme (mae) genes. In gluconeogenic but not in rich media, growth of mutants ¨ppdK and 48 
¨mae was severely impaired and growth of the double ¨fbp-¨glpX mutant was reduced. In 49 
macrophages, only ¨ppdK and ¨mae showed reduced multiplication, and studies with ¨ppdK 50 
confirmed that it reached the replicative niche. Similarly, only ¨ppdK and ¨mae were attenuated 51 
in mice, the former being cleared by week 10 and the latter persisting longer than 12 weeks. We 52 
also investigated the glyoxylate cycle. Although aceA (isocitrate lyase) promoter activity was 53 
enhanced in rich medium, aceA disruption had no effect in vitro or on multiplication in 54 
macrophages or mouse spleens. The results suggest that B. abortus grows intracellularly using 55 
a limited supply of 6 C (and 5 C) sugars that is compensated by glutamate and possibly other 56 













Brucella is a genus of gram-negative bacteria that groups the causative agents of 68 
brucellosis, a worldwide-extended zoonosis severely affecting animal production and human 69 
welfare. Three species, B. abortus, B. melitensis and B. suis, are the most common causes of 70 
brucellosis in domestic livestock and humans. These brucellae can grow both in vitro and within 71 
host cells, and their pathogenicity results largely from their capacity to escape a prompt 72 
detection by innate immunity and the use of a type IV secretion system to reach the replicative 73 
niche, an endoplasmic reticulum derived vacuole (1-6). In this compartment, these bacteria 74 
multiply extensively, which shows their ability to use efficiently substrates provided by the host. 75 
However, there is only sparse information on either the nature of these substrates or the 76 
metabolic pathways used in the replicative niche (7).  77 
In vitro, most strains of B. abortus, B. melitensis and B. suis grow in several simple 78 
chemically defined media (8). Among these, Gerhardt’s medium contains glycerol, lactate, 79 
glutamate and mineral salts plus nicotinic acid, thiamine, pantothenic acid and biotin as growth 80 
factors. This medium supports growth better than other simple defined media, including those 81 
that provide glucose as the C source (8), and this has been attributed to the ability of these 82 
bacteria to use glutamate very efficiently through the tricarboxylic acid cycle (TCA) (9). Indeed, 83 
growth in this medium is clear proof of the ability of these bacteria to carry out gluconeogenesis 84 
in vitro. Concerning the catabolism of glucose, it has been accepted that it proceeds through the 85 
pentose phosphate pathway (in conjunction with TCA), rather than through the glycolysis or 86 
Entner–Doudoroff pathways (Fig. 1). This view, although supported by early radiorespirometric 87 
and enzymatic studies (10,11) performed with the attenuated B. abortus S19 vaccine, is not 88 
consistent with the presence of the genes putatively encoding all the enzymes of the Entner-89 
Doudoroff pathway (12). It is possible that the multiple defects in S19 (13) and/or the 90 
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experimental conditions in those early experiments precluded detection of key enzymes of the 91 
Entner-Doudoroff pathway (12). 92 
Concerning intracellular metabolism, some data come from randomly obtained mutants that 93 
show attenuation in human or mouse macrophages or in HeLa cells. Genes (putative functions) 94 
identified in this manner include, in B. suis 1330, a gguA homologue (gluP, presumably involved 95 
in sugar uptake), some erythritol catabolism genes, gnd (6-phosphogluconate dehydrogenase, 96 
required for using glucose through the pentose phosphate pathway), rbsk (ribose kinase), pyc 97 
(anaplerotic pyruvate carboxylase), pgi (phosphoglucose isomerase) and genes related to the 98 
biosynthesis of amino acids (14-16); in B. melitensis 16M, dbsA and ugpA (ribose and glycerol-99 
3-phosphate transporters, respectively), glpD (glycerol-3-phosphate dehydrogenase) and some 100 
erythritol catabolism genes (17,18); and in B. abortus 2308, gluP (previously shown to encode 101 
an active glucose and galactose transporter in this species (19)), gnd (6-phosphogluconate 102 
dehydrogenase), gltD (glutamate synthase) and gcvB (glycine dehydrogenase) (20). Also in B. 103 
abortus 2308, dxs (an isoprenoid biosynthesis transketolase) and mocC (rhizopine or inositol 104 
catabolism) were identified as expressed in macrophages using a fluorescent reporter (21). 105 
Proteomic analyses have also provided clues on the metabolism of brucellae in the host. 106 
Forty-eight h after infection of mouse macrophages with B. suis 1330, Al Dahouk et al. (22) 107 
found an important reduction of proteins putatively involved in energy, protein and nucleic acid 108 
metabolism. Some exceptions were ribitol kinase, glyceraldehyde-3-P-dehydrogenase and the 109 
isocitrate lyase (AceA) of the glyoxylate cycle. However, other studies in B. suis 1330 do not 110 
support the use of the glyoxylate cycle within host cells (15). Lamontagne et al. (23) analyzed B. 111 
abortus 2308 protein expression 3, 20 and  44 h after infection of RAW 264.7 macrophages. 112 
They found that multiple proteins associated with sugar uptake, TCA, the pentose phosphate 113 
shunt and the subsequent generation of pyruvate were down-regulated 3 h after infection. At 24 114 
h, several proteins involved in sugar metabolism and transport were also reduced. Enzymes 115 
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associated with protein and amino acid catabolism were mainly increased early (3 h) but also 24 116 
h after infection, when bacteria were already in vacuoles derived from the endoplasmic 117 
reticulum. This was also the case of enzymes involved in glutamate synthesis, suggesting 118 
conversion of amino acids into glutamate and α-ketoglutarate. Accordingly, amino acid-based 119 
alternatives may be the preferred solution for B. abortus to derive precursors for the TCA cycle 120 
and ancillary routes during the midpoint time course of infection. At later times, the same authors 121 
observed an increase in proteins involved in transport, suggesting that the endoplasmic 122 
reticulum is able to supply at least some of the substrates required for bacterial growth. 123 
Likewise, the pentose phosphate shunt seemed to partially resume its functions. 124 
Although the information given by these studies is valuable, the central metabolic pathways 125 
used by Brucella during infection remain unclear. The results are contradictory in some cases, 126 
as for the glyoxylate cycle or the metabolic activity in cells. In addition, some studies suggest the 127 
availability of sugars in the replicative niche whereas others indicate that amino acids could be 128 
the preferred C source in vivo, which may require a gluconeogenic metabolism. Indeed, 129 
apparently conflicting data may result from the use of different host cell lines, different times of 130 
analysis, polarity of mutations and other experimental conditions. Moreover, there might be 131 
some variation among B. suis 1330, B. melitensis 16M and B. abortus 2308, as suggested by 132 
the known differences in oxidative rates of sugars and amino acids (24). In this work, we attempt 133 
to answer some aspects of the central metabolic pathways used by B. abortus in the host. For 134 
this purpose, we focused our research on genes putatively involved in classical 135 
gluconeogenesis, the anabolic pathways bridging TCA and the triose-phosphate pathway, and 136 
the glyoxylate cycle. We constructed in-frame mutants in genes coding for key enzymes and 137 
tested them in complex and chemically defined media and for multiplication within cultured cells 138 
and for persistence in the mouse model (25). Together with some of the previous analyses, our 139 
observations suggest a model of B. abortus metabolism in which, although TCA supplies 140 
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molecules necessary for biosynthesis and subsequent growth, classical fructose-1,6-141 
bisphosphatases Fbp and GlpX are not necessary and 6 and/or 5 C molecules for polymer 142 
biosynthesis are obtained mostly from the intracellular milieu. 143 
MATERIAL AND METHODS  144 
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this study 145 
are listed in Table 1S (supplemental material), and their origin and characteristics are described 146 
in previous works (26-28). The strains resulting from the genetic manipulations described below 147 
were characterized according to standard Brucella typing procedures: i.e. colonial morphology 148 
after 3 days of incubation at 37ºC, crystal violet-oxalate exclusion, urease, acriflavine 149 
agglutination, sensitivity to Tb, Wb, Iz and R/C phages, agglutination with anti-A and anti-M 150 
monospecific sera, CO2 and serum dependence, and susceptibility to thionin blue, fuchsin and 151 
safranin (24). Bacteria were routinely grown in standard Peptone-Yeast Extract-Glucose broth 152 
(Biomerieux) or in this media supplemented with agar (TSA). The following antibiotics were used 153 
at the indicated concentrations: kanamycin (Km; 50 ȝg/mL), nalidixic acid (Nal; 25 ȝg/mL), 154 
chloramphenicol (Cm; 20 μg/mL) and/or gentamicin (Genta; 100 ȝg/mL or 25 ȝg/mL) (all from 155 
Sigma). When needed, media was supplemented with 5% sucrose (Sigma). All strains were 156 
stored at – 80ºC in skim milk (Scharlau). To study the phenotype of the metabolic mutants, 157 
Peptone-Yeast Extract-Glucose or the medium of Gerhardt (henceforth Glutamate-Lactate-158 
Glycerol) were used (29). The components (for 1 L) of the latter were: glycerol (30 g), lactic acid 159 
(5 g), glutamic acid (1.5 g), thiamine (0.2 mg), nicotinic acid (0.2 mg), pantothenic acid (0.04 160 
mg), biotin (0.0001 mg), K2HPO4 (10 g), Na2S2O3·5H2O (0.1 g), MgSO4 (10 mg), MnSO4 (0.1 161 
mg), FeSO4 (0.1 mg), NaCl (7.5 g). The pH was adjusted to 6.8-7.  162 
Growth measurements. Inocula pre-conditioned to the conditions in the test medium (Peptone-163 
Yeast Extract-Glucose, Glutamate-Lactate-Glycerol, Glycerol-Glutamate, Glycerol-Lactate or 164 
Glutamate-Lactate) were prepared as follows. First, the strains to be tested were inoculated into 165 
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10 mL of Peptone-Yeast Extract-Glucose in a 50 mL flask and incubated at 37ºC with orbital 166 
shaking for 18 h. These exponentially growing bacteria were harvested by centrifugation, 167 
resuspended in 5 mL of the test medium at an optical density (O.D.600nm) of 0.1 and incubated at 168 
37ºC with orbital shaking for 18 h. Then, these pre-conditioned bacteria were harvested by 169 
centrifugation, resuspended at an O.D.600nm of 0.1 (0.05 starting in the Bioscreen apparatus) in 170 
the same test medium in Bioscreen multi-well plates (200 ȝL/well) and cultivated in a Bioscreen 171 
C (Lab Systems) apparatus with continuous shaking at 37ºC. Absorbance values at 420-580nm 172 
were automatically recorded at 0.5 h intervals over a 120 to 300 h period. All experiments were 173 
performed in triplicate. Controls with culture medium and no bacteria were included in all 174 
experiments. 175 
DNA manipulations. Genomic sequences were obtained from the Kyoto Encyclopedia of 176 
Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/). Searches for DNA and 177 
protein homologies were carried out using the National Center for Biotechnology Information 178 
(NCBI; http://www.ncbi.nlm.nih.gov/) and the European Molecular Biology Laboratory (EMBL) - 179 
European Bioinformatics Institute server (http://www.ebi.ac.uk/). Primers were synthesized by 180 
Sigma-Genosys (Haverhill, UK). DNA sequencing was performed by the “Servicio de 181 
Secuenciación del Centro de Investigación Médica Aplicada” (Pamplona, Spain). Restriction-182 
modification enzymes were used under the conditions recommended by the manufacturer. 183 
Plasmid and chromosomal DNA were extracted with Qiaprep spin Miniprep (Qiagen) and 184 
Ultraclean Microbial DNA Isolation kits (Mo Bio Laboratories), respectively. When needed, DNA 185 
was purified from agarose gels using the Qiack Gel extraction kit (Qiagen).  186 
In-frame deletion mutants in fbp and glpX were constructed by polymerase-chain 187 
reaction (PCR) overlap using genomic DNA of B. abortus 2308 as the DNA template. Primers 188 
were designed using the B. abortus 2308 sequences available in KEGG 189 
(http://www.genome.jp/kegg/). For the construction of the fbp mutant, two PCR fragments were 190 
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generated: oligonucleotides fbp-F1(5ƍ-GTAGCCAAAAAGCCCAGGT-3ƍ) and fbp-R2 (5ƍ-191 
GCCAACCAGAACCAGAGGA-3ƍ) were used to amplify a 203 bp fragment including codons 1–192 
14 of the fbp ORF as well as a 161 bp fragment upstream of the fbp start codon, and 193 
oligonucleotides fbp-F3 (5ƍ-TCCTCTGGTTCTGGTTGGCGTGGCCGAAGAGGTGGATA-3ƍ) and 194 
fbp-R4 (5ƍ-CATTTGCCGCTTCCATGA-3ƍ) were used to amplify a 193 bp fragment including 195 
codons 327-341 of the fbp ORF and a 148 bp fragment downstream of the fbp stop codon. Both 196 
fragments were ligated by PCR using oligonucleotides fbp-F1 and fbp-R4 for amplification, and 197 
the complementary regions between fbp-R2 and fbp-F3 for overlapping. The resulting fragment, 198 
containing the fbp deletion allele, was cloned into pCR2.1 (Invitrogen) to generate plasmid pAZI-199 
1, sequenced to ensure that the reading frame was maintained, and subcloned into the BamHI 200 
and the XbaI sites of the suicide plasmid pJQKm (30). The resulting mutator plasmid (pAZI-2) 201 
was introduced into B. abortus 2308 by conjugation (26). Integration of the suicide vector was 202 
selected by Nal and Km resistance, and the excisions (generating both the fbp mutant 203 
[BAB¨fbp] and a sibling revertant strain carrying an intact gene [BABfbp-sibling revertant]) were 204 
then selected by Nal and sucrose resistance and Km sensitivity. The resulting colonies were 205 
screened by PCR with primers fbp-F1 and fbp-R4, which amplified a fragment of 396 bp in the 206 
mutant and a fragment of 1332 bp in the sibling revertant strain. The mutation resulted in the 207 
loss of about 98% of the fbp ORF and the mutant strain was called BABΔfbp.  208 
The glpX mutant was constructed in a similar way. Primers glpX-F1 (5ƍ-209 
ACGGTGATTCTGGTGACACA-3ƍ) and glpX-R2 (5ƍ-CGAGCTCCAGTGTGAGAATG-3ƍ) were 210 
used to amplify a 576 bp fragment including 61 bp of the glpX ORF as well as 515 bp upstream 211 
of the glpX start codon, and primers glpX-F3 (5ƍ-212 
CATTCTCACACTGGAGCTCGATACGACAGATCCGGACGAG-3ƍ) and glpX-R4 (5ƍ-213 
CATCATACAGTTGCCGATGG-3ƍ) were used to amplify a 574 bp fragment including 371 bp of 214 
the glpX ORF and 203 bp downstream of the glpX stop codon. Both fragments were ligated by 215 
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overlapping PCR using primers glpX-F1 and glpX-R4, and the fragment containing the deletion 216 
allele was cloned into pCR2.1 to generate plasmid pAZI-3, sequenced to confirm that the glpX 217 
ORF had been maintained, and subcloned in pJQKm to produce the mutator plasmid pAZI-4. 218 
This plasmid was then introduced into B. abortus 2308 and the deletion mutant generated by 219 
allelic exchange was selected by Nal and sucrose resistance and Km sensitivity and by PCR 220 
using oligonucleotides glpX-F1 and glpX-R4, which amplified a fragment of 1150 bp in the 221 
deletion strain and a fragment of 1705 bp in the BABglpX-sibling revertant strain. The mutation 222 
resulted in the loss of approximately 56% of the glpX ORF, and the mutant was called 223 
BABΔglpX. 224 
To construct the BABΔfbpΔglpX double mutant, the mutator plasmid pAZI-4 was 225 
introduced into strain BABΔfbp. After allelic exchange, the double mutant was selected as 226 
described above using primers glpX-F1 and glpX-R4.  227 
BABΔaceA was constructed using the same strategy. Oligonucleotides aceA-F1 (5ƍ-228 
TGACAAGATATCGCCAAAACAC-3ƍ) and aceA-R2 (5ƍ-CGAAGGGATGAGGCTGTAAA-3ƍ) 229 
amplified a 238 bp fragment, including codons 1-10 of the aceA ORF and 208 bp upstream of 230 
the aceA start codon. Oligonucleotides aceA-F3 (5ƍ-TTTACAGCC 231 
TCATCCCTTCGGAAACCGCACAGTTCAAGC-3ƍ) and aceA-R4 (5ƍ-GGATCAAGAGATCA 232 
CCCCAGT-3ƍ) amplified a 278 bp fragment including codons 420-430 of the ORF aceA and 245 233 
bp downstream of the aceA stop codon. Both fragments were ligated by overlapping PCR using 234 
oligonucleotides aceA-F1 and aceA-R4. The PCR product was cloned into pCR2.1 to generate 235 
pAZI-7, sequenced and subcloned into pJQKm to produce the suicide plasmid pAZI-8. B. 236 
abortus 2308 mutants were selected by PCR using oligonucleotides aceA-F1 and aceA-R4. 237 
PCR products were 1743 bp in BABaceA-sibling revertant strain and 738 bp in BABΔaceA. This 238 
mutation eliminated 78% of the aceA ORF. 239 
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For the construction of the pckA mutant, oligonucleotides pckA-F1 (5’-240 
TGTTTGCAGTTTTCCACACC-3’), pckA-R2 (5’-AATCGAAGCGGCCTTATTGT-3’), pckA-F3 (5’-241 
ACAATAAGGCCGCTTCGATTGACGGCTCGCTGAACAAT-3’) and pckA-R4 (5’-TCTTGCGA 242 
TAACAGCCAAAA-3’) were used. Primes pckA-F1 and pckA-R2 amplified a 219 bp fragment, 243 
which included codons 1-13 of the pckA ORF and 180 bp upstream of the pckA start codon. 244 
Primers pckA-F3 and pckA-R4  amplified a 319 bp fragment including the last 37 codons of the 245 
pckA ORF and 208 bp downstream of the pckA stop codon. Both PCR products were ligated by 246 
overlapping PCR using pckA-F1 and pckA-R4, cloned into pCR2.1 to generate plasmid pAZI-5 247 
and subsequently subcloned into the BamHI and the XbaI sites of the suicide plasmid pJQKm. 248 
The resulting mutator plasmid pAZI-6 was introduced into B. abortus 2308, where it was 249 
integrated in the chromosome. A second recombination generated the excision of the plasmid. 250 
The resulting colonies were screened by PCR (with pckA-F1 and pckA-R4) amplifying a 251 
fragment of 538 bp in the mutant and a fragment of 1864 bp in the sibling revertant strain. The 252 
mutant strain was called BABΔpckA and lacked the 71.14% of the pckA ORF. 253 
BABΔppdK was constructed using primers ppdK-F1(5´-CTCCCGATTCATTTTTCACG-3´) 254 
and ppdK-R2 (5ƍ- TGCTCATTTCAGCCAGGTT-3ƍ) to amplify a 288-bp fragment including the 255 
first 103 bp of the ppdK ORF, as well as 185 bp upstream of the ppdK start codon and primers 256 
ppdK-F3 (5ƍ-AACCTGGCTGAAATGAGCACGGGTCTCGACTATGTGTCC-3ƍ) and ppdK-R4 (5ƍ-257 
TCAACGCATCAAAGCAGAAG-3ƍ) to amplify a 220 bp including the last 86 bp of the ppdK ORF 258 
and 134 bp downstream of the ppdK stop codon. Both fragments were ligated by overlapping 259 
PCR using primers ppdK-F1 and ppdK-R4 and the fragment obtained, containing the deletion 260 
allele, was cloned into pCR2.1 to generate pMZI-1, sequenced to confirm that the reading frame 261 
had been maintained, and subcloned into pJQKm to produce the mutator plasmid pMZI-2. This 262 
plasmid was introduced into B. abortus 2308 and both the deletion mutant and the sibling 263 
revertant strain generated by allelic exchange was selected by Nal and sucrose resistance and 264 
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Km sensitivity, and by PCR using ppdK-F1 and ppdK-R4 which amplified a fragment of 508 bp in 265 
BABΔppdK and a fragment of 2983 bp in BABppdK-sibling revertant strain. The mutation 266 
generated resulted in the loss of the 93% of ppdK.  267 
Primers ppdKII-F1 (5’-CTCCCGATTCATTTTTCACG-3’), ppdKII-R2 (5’-268 
CTGCTCATTTCAGCCAGGTT-3’), ppdKII-F3 (5’-269 
AACCTGGCTGAAATGAGCAGCGGGTCTCGACTATGTGTCC-3’) and ppdKII-R4 (5’-270 
TCAACGCATCAAAGCAGAAG-3’) were used to obtain the mutator plasmid pAZI-10. This 271 
plasmid was introduced into B. abortus 2308 to obtain a ppdK mutant that maintained only the 272 
34 first amino acids of PpdK (BABΔppdK-II). This mutant had the same phenotype as the one 273 
previously described. Thus, the mutator plasmid pAZI-10 was also introduced into strain 274 
BABΔpckA carrying the pckA mutation to obtain the double mutant BABΔpckAΔppdK.  275 
BABΔmae was constructed using primers mae-F1 (5ƍ-TATGACGGCGCACTTGTCTA-3ƍ) 276 
and mae-R2 (5ƍ-TCGGATAGCGATGGAAGAAC -3ƍ) to amplify a 341 bp fragment including 76 277 
bp of the mae ORF, as well as 265 bp upstream of the mae start codon, and primers mae-F3 (5ƍ-278 
GTTCTTCCATCGCTATCCGAGCGAAGCCAATCTTCTGGTA -3ƍ) and mae-R4 (5ƍ-279 
CGCCATAAAACGAACCTCAA-3ƍ) to amplify a 376 bp including 227 bp of the mae ORF and 280 
149 bp downstream of the mae stop codon. Both fragments were ligated by overlapping PCR 281 
using primers mae-F1 and mae-R4 and the fragment obtained, containing the deletion allele, 282 
was cloned into pCR2.1 to generate pMZI-3, sequenced to confirm that the mae ORF had been 283 
maintained, and subloned into pJQKm to produce the mutator plasmid pMZI-4. This plasmid was 284 
then introduced into B. abortus 2308 and the mutant and sibling revertant strains generated by 285 
allelic exchange were selected by Nal and sucrose resistance and Km sensitivity and by PCR 286 
using oligonucleotides mae-F1 and mae-R4, which amplified a fragment of 717 bp in the deleted 287 
strain and a fragment of 2739 bp in the sibling revertant strain. The mutation generated resulted 288 
in the loss of the 87% of the mae ORF. 289 
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To check the different mutations, we used internal primers (gene-R5) hybridizing in the deleted 290 
regions.  291 
For complementation, a plasmid carrying ppdK was constructed using the Gateway cloning 292 
Technology (Invitrogen). Since the sequence of ppdK from B. abortus and B. melitensis is 99% 293 
identical, the clone carrying ppdK was extracted from the B. melitensis ORFEOMA and the ORF 294 
subcloned into plasmid pRH001 (31) to produce plasmid pAZI-19. This plasmid was introduced 295 
into BAB¨ppdK by mating with E. coli S17 Ȝpir and the conjugants harboring this plasmid 296 
(designated as BAB¨ppdK pAZI-19) were selected by plating the mating mixture onto tryptic soy 297 
agar (TSA)-Nal-Km plates. For the construction of BAB¨fbp¨glpX pAZI-21, gene fbp was 298 
amplified from BAB-parental using primers fbp-Fp (5ƍ-299 
GGGATCCATGCTTCTGAAAGGGTGGTACCG-3ƍ) and fbp-R4 (5ƍ-CATTTGCCGCTTCCATGA-300 
3ƍ) and cloned into pCR2.1. The resulting plasmid was sequenced, and the fbp gene was 301 
subcloned into the BamHI and the XhoI sites of the vector pBBR1MCS1. The resulting plasmid 302 
(pAZI-21) was introduced into BAB¨fbp¨glpX by conjugation (see above). BAB¨fbp¨glpX pAZI-303 
23 was constructed following the same strategy using primers glpX-F1 (5ƍ-304 
ACGGTGATTCTGGTGACACA-3ƍ) and glpX-R4 (5ƍ-CATCATACAGTTGCCGATGG-3ƍ) to amplify 305 
glpX. 306 
Gene expression studies. To determine whether aceA was expressed in vitro, its promoter was 307 
fused with the luciferase reporter gene. To this end, aceAp-F (5’-308 
GGGATCCTAGTTGCGCTCGATCAGATT-3’) and aceAp-R (5’-309 
TTCTAGACATTTCGGTGTCTCCTCGT-3’) (respectively containing BamHI and XbaI sites; 310 
underlined) were used to amplify a 382bp region containing the ATG and the aceA promoter 311 
from B. abortus 2308 genomic DNA. This PCR product was verified by electrophoresis and 312 
ligated into the vector pGEM-T Easy (Promega), thereby originating plasmid pAZI-17. Then, the 313 
insert was digested with BamHI and XbaI and ligated to the pSKOriTKmluxAB to generate 314 
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plasmid pAZI-18. This plasmid was introduced into E.coli S17λ pir Nals and then transferred by 315 
conjugation to B. abortus 2308 NalR KmS. Cells were plated on TSA NalKm. Positive clones 316 
gave a 510 bp band when verified by PCR using aceAp-F and luxAB-R. The resulting strain was 317 
called B. abortus pBABaceA-luxAB. To measure luciferase activity, fresh B. abortus pBABaceA-318 
luxAB were adjusted (OD600nm) to 0.4 in saline and finally, 50 or 200 ȝL were added to flasks with 319 
10 mL of Peptone-Yeast Extract-Glucose or Glutamate-Lactate-Glycerol, respectively. Growth 320 
was followed by measuring absorbance at OD600nm and 1 mL aliquots were taken at selected 321 
intervals to measure the luminescence in Relative Luminescence Units (RLU) after addition of 322 
100 ȝL ethanol:decanal (1:1).  323 
Cell infections and intracellular trafficking. In vitro infection assays were performed in RAW 324 
264.7 macrophages (ATCC TIB-71) and HeLa cells (ATCC CCL-2) cultured in Dulbecco's 325 
Modified Eagle Medium (DMEM; Gibco) with 10% (v/v) heat-inactivated fetal bovine serum 326 
(Gibco), 1% (v/v) L-glutamine 200 nM (Sigma Aldrich) and 1% (v/v) non-essential amino acids 327 
(Gibco). Then, 24-well plates were seeded with 1 × 105 cells/well, and macrophages and HeLa 328 
cells were infected at a multiplicity of infection of 50:1 and 200:1 (bacteria:cell), respectively, by 329 
centrifuging the plates at 400 × g for 10 min at 4°C. After incubation for 15 min at 37°C under a 330 
5% CO2 atmosphere, extracellular bacteria were removed with four DMEM washes followed by 331 
Genta treatment (100 ȝg/mL) for 90 min. Then, fresh medium supplemented with 25 ȝg/mL of 332 
Genta was added and incubation carried on. Two, 24 and 48 h later, cells were washed three 333 
times with 100 mM phosphate buffered saline (pH 7.2), lysed with 0.1% (v/v) Triton X-100 in 334 
phosphate buffered saline, and plated on TSA to determine the number of intracellular bacteria. 335 
All experiments were performed in triplicate (32). Results were expressed as mean and standard 336 
error (n=3) of individual log10 CFU/well. Statistical comparison of means was performed by a 337 




For immunofluorescence microscopy, RAW 264.7 macrophages and HeLa cells were 340 
grown on coverslips and inoculated with bacteria as described above. Cells were fixed in 3% 341 
paraformaldehyde in 100 mM phosphate buffered saline (pH 7.2) at 37°C for 10 min. Cells were 342 
washed twice with phosphate buffered saline and permeabilized with 0.1% (v/v) Triton X-100 343 
and 3% bovine serum albumin (Sigma), for 30 min. Coverslips were incubated with primary 344 
antibodies for 45 min at room temperature, washed three times in the same phosphate buffered 345 
saline supplemented with 3% bovine serum albumin, and then incubated with the appropriate 346 
secondary antibodies. Coverslips were washed three times with phosphate buffered saline and 347 
once with H2O and mounted onto glass slides using Mowiol 4–88. Samples were examined and 348 
images acquired using a Leica TCS SP5 laser scanning confocal microscope at the “UNAmur“ 349 
(Namur, Belgium). The primary antibodies used for immunofluorescence microscopy were rabbit 350 
anti-calnexin (SPA-860, Stressgen) and a mouse anti-S-LPS monoclonal antibody 351 
(A76/12G12/F12). The secondary antibodies were donkey anti-rabbit IgG conjugated to Alexa 352 
Fluor 488, (Invitrogen), and goat anti-mouse IgG conjugated to Alexa Fluor 546 (Invitrogen). For 353 
lysosomal labeling, the primary antibody used was rat anti-mouse (DBHS) and the secondary 354 
antibody was goat anti-rat anti IgG conjugated to Alexa Fluor 633 (Invitrogen). 355 
Assays in mice. Female BALB/c mice (Charles River, France) were kept in cages with water 356 
and food ad libitum, and accommodated under P3 biosafety containment conditions 2 weeks 357 
before and during the experiments, in the facilities of the "Instituto de Agrobiotecnología" 358 
(registration code ES/31-2016-000002-CR-SU-US). The animal handling and other procedures 359 
were in accordance with the current European (directive 86/609/EEC) and Spanish (RD 360 
53/2013) legislations, supervised by the Animal Welfare Committee of the "Universidad Pública 361 
de Navarra", and authorized by the competent authority of "Gobierno de Navarra". To prepare 362 
inocula, TSA grown bacteria were harvested, adjusted spectrophotometrically (O.D.600nm =0.170) 363 
in 10 mM phosphate buffered saline (pH 6.85) and diluted in the same diluent up to 364 
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approximately 5 × 105 colony forming units (CFU)/mL (exact doses were assessed 365 
retrospectively).For each bacterial strain, five mice were intraperitoneally inoculated with 0.1 366 
mL/mouse and the CFU number in spleen was determined at different weeks post-inoculation as 367 
described previously (33). The identity of the spleen isolates was confirmed by PCR. The 368 
individual number of CFU/spleen was normalized by logarithmic transformation, and the mean 369 
log CFU/spleen values and the standard deviation were calculated for each group of mice (n=5). 370 
Statistical comparisons were performed by a one-way ANOVA followed by the Fisher’s 371 
Protected Least Significant Differences (PLSD) tests (33). 372 
RESULTS 373 
Dysfunction of B. abortus fbp, glpX, ppdK and mae but not of pckA or aceA homologues 374 
affects growth on gluconeogenic substrates in vitro. The conversion of fructose-1,6-bisP 375 
into fructose-6-P mediated by the cognate bisphosphatase(s) (FBPases) is the only irreversible 376 
step among those taking part in gluconeogenesis in Brucella (Fig. 1). Therefore, FBPase activity 377 
is strictly necessary to grow under gluconeogenic conditions.  378 
As in E. coli and Salmonella, the B. abortus 2308 genome presents two ORFs of putative 379 
FBPases: BAB2_0364 and BAB1_1292. The former is predicted to encode a protein of 340 380 
amino acids that belongs to the class I FBPases (Fbp), and the latter a 328 amino acid protein 381 
ortholog to E. coli GlpX, a FBPase of class II (Fig. 1). In E. coli, Fbp is connected to the 382 
production of fructose-6-phosphate for nucleotide, polysaccharide and aromatic amino acid 383 
biosynthesis. GlpX, on the other hand, belongs to an operon (glpFKX) related to phospholipid 384 
biosynthesis (34). The putative B. abortus glpX, however, seems isolated and not part of any 385 
obvious operon. 386 
We constructed mutants carrying in frame deletions in the putative fbp (BABǻfbp mutant) 387 
and glpX (BABǻglpX) as well as in both genes (BABǻfbpǻglpX), and tested their growth in a 388 
complex (Peptone-Yeast Extract-Glucose) medium and in the chemically defined medium of 389 
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Gerhardt (Glutamate-Lactate-Glycerol). In the complex medium, the three mutants grew with 390 
generation times and final yields similar to those of B. abortus 2308 (BAB-parental) (Fig. 2A.1). 391 
BAB-parental showed reduced growth rates and final yields in Glutamate-Lactate-Glycerol, as 392 
expected, and we obtained identical results with either BABǻfbp or BABǻglpX (Fig. 2A.2). On 393 
the other hand, BABǻfbpǻglpX produced a markedly lower increase in turbidity in the minimal 394 
medium (Fig. 2A.2). Complementation with plasmid pAZI-21 carrying fbp or with pAZI-23 395 
carrying glpX restored the ability to grow in Glutamate-Lactate-Glycerol to levels close to that of 396 
the parental strain (Supplemental Material; Fig. S3). These experiments strongly suggest that B. 397 
abortus Fbp and GlpX are functional, an interpretation reinforced by their reciprocal 398 
complementation (i.e., Fbp complemented BABǻglpX and, conversely, GlpX complemented 399 
BABǻfbp). We then tested combinations of two C sources (Glycerol-Glutamate, Glycerol-Lactate 400 
or Glutamate-Lactate). Whereas BABǻglpX was not affected, BABǻfbp showed retarded growth 401 
only in the absence of glycerol (i.e. in Glutamate-Lactate; Fig. 3, upper panels). Since GlpX is 402 
the FBPase remaining in BABǻfbp and this mutant grew normally when glycerol was present, 403 
this result suggests that, as in E. coli (34), GlpX is related to glycerol metabolism. Finally, 404 
although retarded and diminished, the double BABǻfbpǻglpX mutant still showed significant 405 
growth (Fig. 3, upper panels). 406 
During these experiments we noticed that BABǻfbpǻglpX inoculated broths did not produce 407 
a homogeneous growth. This was clearly observed when the double mutant was grown in 408 
Glutamate-Lactate-Glycerol in side-arm flasks instead of the automated Bioscreen system. 409 
Under these conditions, the bacteria formed macroscopic aggregates (Fig. 4) settling on the 410 
bottom of the flasks that indicated a profound surface modification consistent with an altered 411 
biosynthesis of envelope molecules. In summary, although Fbp and GlpX deficiency did not 412 
abrogate bacterial multiplication, they were required not only for full growth but also for 413 
production of normal cells. 414 
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Next, we investigated the pathways that supply pyruvate or PEP for gluconeogenesis. For 415 
this purpose, we carried out a genomic search for homologues of the genes encoding the 416 
enzymes connecting the TCA cycle and the triose-phosphate pathway in bacteria (Fig. 1). We 417 
identified homologues of pdh (pyruvate dehydrogenase), pyk (pyruvate kinase), pckA 418 
(phosphoenolpyruvate carboxykinase), ppdK (pyruvate-phosphate dikinase), pyc (pyruvate 419 
carboxylase), and mae (malic enzyme) but not of pyrcK (pyruvate carboxykinase), pps 420 
(phosphoenolpyruvate synthase) or ppc (phosphoenolpyruvate carboxylase) (Fig. 1). Since Pyc, 421 
Pdh and Pyk catalyze irreversible catabolic steps, we studied the pckA, ppdK and mae 422 
homologues. 423 
B. abortus 2308 BAB1_2091 is annotated as a pseudogene in some data bases 424 
(http://www.genome.jp/kegg/) but not in others (http://biocyc.org.). This ORF encodes a protein 425 
of 491 amino acids that bears a 77% similarity with the PckA of the phylogenetically related 426 
Agrobacterium tumefaciens, a protein of 536 amino acids known to be functional (35). However, 427 
B. abortus BAB1_2091 is separated by a stop codon from an intergenic region that together with 428 
BAB1_2090 encodes the last 45 amino acids present in A. tumefaciens PckA. The frame-shift 429 
that generates this stop codon is present also in all B. abortus strains sequenced so far 430 
(http://www.genome.jp/kegg/). Nevertheless, B. abortus PckA conserves the IGGTSYAGE-KKS 431 
domain (amino acids 190 to 202) specifically required for the carboxykinase activity (36) as well 432 
as the phosphate binding site (G--G-GKT; amino acids 236 to 243) and ATP and metal binding 433 
sites, so that its functionality is not obviously compromised. In contrast, the putative B. abortus 434 
2308 PpdK (encoded by BAB1_0525) represents a complete protein of 887 amino acids with the 435 
PEP-binding (amino acids 19 to 376) and the TIM-barrel (amino acids 530 to 883) domains 436 
characteristic of PEP-utilizing enzymes.  437 
To test whether these ORFs encoded enzymes are required for growth under gluconeogenic 438 
conditions, we constructed the non-polar mutants BABΔpckA and BABΔppdK. Moreover, since 439 
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both PckA and Ppdk catalyze reactions eventually leading to PEP (Fig. 1), we excluded their 440 
reciprocal complementation by constructing the double mutant BABΔpckAΔppdK. We then 441 
compared the growth of BAB-parental and the mutants in Peptone-Yeast Extract-Glucose and in 442 
Glutamate-Lactate-Glycerol. Whereas we did not observe differences in the growth of 443 
BABǻpckA and BAB-parental in these two media, both BABǻppdK and BABǻpckAǻppdK had a 444 
markedly reduced growth in Glutamate-Lactate-Glycerol (Fig. 2B). Complementation with 445 
plasmid pAZI-19 carrying ppdK restored the phenotype (Supplemental Material; Fig. S1), and 446 
the sibling revertant control (see Material and Methods) conserved the wild-type phenotype (not 447 
shown). These results strongly suggest that PpdK is functional and that, consistent with the 448 
frame shift in pckA, PckA does not synthesize PEP from oxaloacetate in B. abortus. The 449 
possibility that the role of B. abortus PckA is not detectable under these in vitro conditions 450 
seems less likely. 451 
We followed a similar strategy to study the putative mae. BAB1_1036 encodes a protein of 452 
774 amino acids annotated as a NADP (or NAD)-dependent enzyme involved in malate 453 
metabolism (http://www.genome.jp/kegg/; http://biocyc.org/). The N-terminal domain (amino 454 
acids 28-160) and the NADP (or NAD)-binding domain (amino acids 172-409) characteristic of 455 
the malic enzyme are conserved in the BAB1_1036 predicted protein. Mutant BABΔmae 456 
(deleted in the region encoding amino acids 26 to 673) displayed a small reduction in growth in 457 
Peptone-Yeast Extract-Glucose and a more marked one in Glutamate-Lactate-Glycerol (Fig. 458 
2C). The impairment was not as accentuated as that of BABΔppdK (compare Fig. 2 panels B 459 
and C). In these experiments, mae mutants with the above-described phenotype were 460 
consistently obtained and the control sibling revertants of wild-type phenotype recovered after 461 
the last recombination event (see Material and Methods and Supplemental Material; Fig. S2). 462 
Taken together, these results support the hypothesis that B. abortus Mae supplies pyruvate for 463 
PpdK to produce PEP for gluconeogenesis, lactate being a complementary source of pyruvate in 464 
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Glutamate-Lactate-Glycerol (Fig. 1). We tested this hypothesis further by using media containing 465 
only two of the three C substrates of this chemically defined medium. BABΔmae did not grow in 466 
Glycerol-Glutamate, showed optimal growth in Glycerol-Lactate, and reduced growth in 467 
Glutamate-Lactate (Fig. 3, lower panels). These results are fully consistent with the predicted 468 
role of Mae (Fig. 1) and suggest that, although B. abortus 2308 can use glycerol, glutamate and 469 
lactate, provision of the latter cannot completely replace the Mae pathway. This interpretation is 470 
also supported by the fact that whereas PpdK dysfunction in BABǻppdK severely impaired 471 
growth in Glycerol-Lactate and Glutamate-Lactate, this mutant grew in Glycerol-Glutamate (Fig. 472 
3, lower panels), two substrates able to act as sources of PEP and pyruvate through the triose-P 473 
and Mae pathways, respectively (Fig. 1). Indeed, all these results are in agreement with the 474 
early studies that led to the formulation of the simple medium of Gerhardt as well as with the 475 
nutritional studies that showed the preferential use of glutamate and the complementary role of 476 
glycerol and lactate in B. abortus (9). Also, the demonstration by Marr et al. (37) of the ability of 477 
B. abortus to generate pyruvate (and alanine) from glutamate supports an activity of Mae in this 478 
bacterium (Fig. 1).   479 
Since the putative Mae was active in B. abortus 2308, we investigated whether malate 480 
replenishment could occur through the classical glyoxylate pathway (Fig. 1) or the PEP-481 
glyoxylate cycle. The latter cycle combines the operation of PckA with the glyoxylate cycle 482 
enzymes and operates in E. coli under conditions of glucose limitation (38). In these pathways, 483 
isocitrate lyase (AceA) cleaves isocitrate to yield glyoxylate and succinate, and a malate 484 
synthase (AceB) condenses glyoxylate and acetyl-CoA to produce malate (39-41). The genome 485 
of B. abortus 2308 carries only one putative aceA (ORF BAB1_1631) and one putative aceB 486 
(ORF BAB1_1663). The predicted AceA is a protein of 429 amino acids with 61% identity and 487 
76% similarity to E. coli AceA, and it conserves the amino acids required for the enzymatic 488 
activity and the assembly of the tetrameric enzyme (42-47). The predicted AceB has 728 amino 489 
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acids with 59% identity and 74% similarity to E. coli malate synthase G, and conserves the 490 
catalytic site and the amino acids interacting with acetyl-CoA (48,49). Accordingly, we 491 
constructed a non-polar BABΔaceA mutant truncated in the 409 central amino acids. This 492 
mutant did not show growth differences with BAB-parental in Peptone-Yeast Extract-Glucose 493 
and Glutamate-Lactate-Glycerol (data not shown), even though these media contain acetogenic 494 
substrates (glucose, glycerol, lactate and serine, threonine and alanine) (50). Since the genomic 495 
analysis strongly suggests the presence of the glyoxylate cycle, we examined this point further 496 
by constructing a luciferase reporter under the control of the AceA promoter. Although growth 497 
curves were similar, luciferase activity was considerably higher in Peptone-Yeast Extract-498 
Glucose than in Glutamate-Lactate-Glycerol (Fig. 5), as expected if the glyoxylate cycle 499 
becomes active on dependence of the abundance of acetogenic substrates. In such a case, the 500 
lack of phenotype in complex media could be explained if the glyoxylate cycle plays only a 501 
subsidiary role in this rich medium, and the experiments do not rule out that the possibility that it 502 
becomes important under other nutritional conditions. 503 
B. abortus mutants in ppdK and mae but not in fbp, glpX, pckA or aceA show lower 504 
multiplication rates in macrophages. B. abortus is characteristically able to multiply 505 
intracellularly in professional phagocytes (51). We thus investigated the ability of the above-506 
described mutants to multiply in macrophages using the parental strain and the attenuated virB 507 
mutant (unable to reach the replicating vacuole) as controls. Figure 6A shows that 508 
BABǻfbpǻglpX replicated like BAB-parental, even though these bacteria differed in growth 509 
under gluconeogenic conditions in vitro (see above). BABΔppdK (Fig. 6B) and BABΔmae (Fig. 510 
6C) multiplied in macrophages, although at lower overall rates than BAB-parental both 24 511 
(p<0,0001) and 48h (p<0,0001) after infection. On the other hand, mutation of pckA had no 512 
effect either by itself or combined with the ppdK deletion (Fig. 6B).  513 
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These results suggest that, albeit impaired in growth, BABΔppdK and BABΔmae are still 514 
able to reach the replicative intracellular niche. Since Mae and PpdK belong to the same 515 
pathway, we selected BABΔppdK (the mutant blocked in the upper step of the pathway; Fig. 1) 516 
to confirm that the metabolic dysfunction did not prevent these bacteria from reaching the 517 
endoplasmic reticulum-derived replicating niche. Figure 7A shows that, in contrast to the virB 518 
mutant, BABΔppdK and the parental bacteria were similar in intracellular distribution.  519 
B. abortus can also penetrate and multiply in epithelial cells (51). We found that the behavior 520 
of BABΔppdK in macrophages was reproduced in HeLa cells (Fig 7A and B). In addition, we 521 
found that the CFU of the mutant and BAB-parental in HeLa cells did not differ 2 h after infection 522 
(not shown), indicating that they were similar with regards to penetration. 523 
B. abortus mutants in ppdK and mae but not in pckA, fbp, glpX or aceA are attenuated in 524 
mice. Virulent B. abortus is able to establish spleen infections in mice that characteristically 525 
develop in four phases: (i), onset phase (spleen colonization; first 48 h); (ii), acute phase (from 526 
the third day to weeks 2-4 when bacteria reach maximal numbers); (iii), chronic steady phase 527 
(weeks 2-4 to 12), where the bacterial numbers plateau; and (iv), chronic declining phase, during 528 
which brucellae are eliminated. The ability to induce a marked splenomegaly is also a 529 
characteristic of virulent brucellae. (25). Using this model, we first studied the BABΔfbpΔglpX 530 
mutant and found that it did not differ from BAB-parental in either the CFU/speen profile or the 531 
splenomegaly induced (Fig. 8A). Similarly, we did not observe attenuation for BABΔpckA (Fig. 532 
8B), which is remarkable because pckA expression increases in B. abortus mutants in 533 
BvrR/BvrS, a master regulator of B. abortus virulence (52). Nevertheless, this result is consistent 534 
with the genomic features of pckA and with the above-described experiments in vitro and in 535 
macrophages. 536 
BABΔppdK failed to reach the chronic steady phase typical of virulent brucellae yielding 537 
significantly lower CFU counts after week 2 (Fig. 8B). Clearly indicative of the strong attenuation 538 
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of BABΔppdK, we did not recover any bacteria from the spleens of 3 out of the 5 mice examined 539 
at post-infection week 12, and this mutant induced less splenomegaly than the virulent bacteria 540 
(Fig. 8B). Consistent with the observations that showed no additive effect of the mutations of 541 
ppdK and pckA in macrophages or in vitro, the results of BABΔpckAΔppdK in mice paralleled 542 
those of BABΔppdK (Fig. 8B). BABΔmae produced a CFU/spleen profile that differed from that of 543 
either BAB-parental or BABΔppdK. Although not affected in the first 48 h (onset phase; not 544 
shown) this mutant showed a lower multiplication rate during the acute phase (Fig. 8C) that was 545 
reminiscent of the lower multiplication rates observed in macrophages. Strikingly, even though 546 
CFU/spleen numbers were lower than those of the wild type strains, BABΔmae produced a 547 
chronic steady phase with reduced splenomegaly.  548 
Finally, we tested BABΔaceA in mice. In a first experiment, the mutant did not show 549 
attenuation at weeks 2, 8 and 12 (not shown). It has been reported that isocitrate lyase is 550 
essential for Salmonella persistence in mice during chronic infection but dispensable for acute 551 
lethal infection (53). Similarly, isocitrate lyase is dispensable in the acute phase of 552 
Mycobacterium tuberculosis infection in lung macrophages of mice but facilitates persistence 553 
during the chronic phase (54). Accordingly, we repeated the mouse infections and determined 554 
the number of BABΔaceA CFU in spleens 16 and 24 weeks later. However, we did not find any 555 
difference between this mutant and the parental strain (not shown). Therefore, even though we 556 
did not rule out the possibility that the glyoxylate cycle plays a role under conditions different 557 
from those tested in vitro, we concluded that this shunt is not essential for B. abortus 558 
multiplication and persistence in the laboratory models used. Since the PEP-glyoxylate pathway 559 
relies on both AceA and PckA, this conclusion can be extended to this cycle.  560 
DISCUSSION 561 
B. abortus lacks the genes necessary for the metabolism of glycogen or poly-beta-562 
hydroxyalkanoates, the two C reserve materials used by prokaryotes (55). Thus, these bacteria 563 
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depend on nutrients provided by the host to multiply intracellularly and, accordingly, they need a 564 
supply of (at least) 6 C skeletons or to carry out gluconeogenesis. To investigate these 565 
possibilities, we deleted ORFs that could be encoding enzymes of critical steps of 566 
gluconeogenesis, or of steps providing the necessary precursors. The genomic characteristics of 567 
the ORFs analyzed and the phenotypes observed in vitro support the hypothesis that they 568 
encode FBPases, a pyruvate phosphate dikinase and a malic enzyme of B. abortus. Moreover, 569 
the analyses in cells show that the proteins coded for by ppdK and mae become necessary once 570 
the replicative niche is reached, as expected from metabolic mutants.  571 
Since FBPases are essential for gluconeogenesis, the observation that growth in 572 
gluconeogenic media was not abolished in the Fbp-GlpX double mutant is intriguing and several 573 
hypotheses can be considered to explain these results. The existence of a third FBPase is the 574 
first and more obvious possibility. Up to now, five different types of FBPases (I to V) have been 575 
described in prokaryotes (56). Whereas FBPases of classes IV and V are restricted to Archaea 576 
and their close hyperthermophilic Aquifex bacterial group, many bacteria have dual 577 
combinations of class I (Fbp homologues), class II (GlpX homologues), and class III FBPases 578 
(34,56). However, a genomic search for Bacillus subtilis YydE homologues (the prototype of 579 
class III FBPases (57)) in the Brucellaceae only revealed an imperfect match (a hypothetical 580 
protein of 218 amino acids with a 32% identity with the 671 amino acids in YydE) in 581 
Ochrobactrum anthropi and none in Brucella. This is in agreement with the fact that no bacterial 582 
genome has been described to carry a combination of classes I and III (34). Also, it has been 583 
described that some E. coli carry two class II FBPases (GlpX and YggF (56)) but genomic 584 
analysis of all phosphatases in B. abortus fail to identify clear candidates for any phosphatase 585 
close to GlpX and Fbp (Supplemental Material; Fig. S4). This genomic evidence and the Fbp-586 
GlpX reciprocal complementation (i.e. the fact that only the double mutant shows phenotype in 587 
vitro in the absence of glycerol) suggest that these are the main and possibly the only FBPases 588 
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in B. abortus. An alternative to the third FBPase hypothesis is the existence of an atypical 589 
gluconeogenesis less efficient than the classical one. Hypothetically, a fructose-6-P aldolase 590 
could take part in gluconeogenesis. This has been described in E. coli K-12 where ORF b0825 591 
encodes an enzyme that catalyzes the reversible conversion of fructose-6-P to 592 
dihydroxyacetone and glyceraldehyde-3-P (58). This aldolase is different from that operating in 593 
the pentose-phosphate cycle and its physiological role is uncertain. However, the only 594 
homologous in B. abortus (ORF BAB1_1813) is annotated as transaldolase and, in addition to 595 
the fact that it should represent the enzyme of the pentose-phosphate cycle, the identity (30%) is 596 
below the threshold considered to be significant (59). Obviously, a rigorous analysis of these two 597 
hypotheses requires enzymatic analysis of double deficient cells. Finally, the significance of the 598 
mucoid aggregates produced by the double FBPase mutant cannot be disregarded since this 599 
phenotype suggests that the growth observed does not correspond to a natural condition. 600 
Bearing in mind that enzymatic analyses are necessary to reach definite conclusions, our 601 
results and those of previous works with B. abortus 2308 offer insight into some global models of 602 
the metabolism of these bacteria during intracellular life in the host.  603 
A first model (gluconeogenic model) can be proposed on the ability of B. abortus to grow in 604 
the defined medium of Gerhardt and on the proteomic studies in macrophages that suggest that 605 
B. abortus shifts to an amino acid-based metabolism in which the glutamate pool is increased 606 
(23). According to this model, molecules like glycerol, lactate or pyruvate and amino acids 607 
channeled to oxaloacetate, keto-glutarate or pyruvate are the main substrates, and molecules of 608 
6 and 5 C are derived from the latter. In this regard, it is remarkable that dysfunction of two 609 
major FBPases did not bring about any perceptible attenuation either in cells or mice. Although 610 
the reduced growth of the BABǻfbpǻglpx mutant in vitro precludes a clear-cut conclusion, the 611 
contrasting in vivo and in vitro multiplication and the mucoid phenotype of the double mutant in 612 
the minimal medium are more consistent with models alternative to the gluconeogenic one. 613 
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Moreover, two lines of evidence indicate that glucose (or closely related hexoses) is available in 614 
the host. First, a B. abortus 2308 (and B. suis 1330) GluP (glucose/galactose transporter) 615 
mutant has been identified as attenuated in signature tagged experiments in (15,20,20). Second, 616 
it has been reported recently that the multiplication of B. abortus in alternatively activated 617 
macrophages increases when the intracellular glucose levels are artificially increased (60). 618 
Based on these observations, an almost opposite model proposes a main role for 6 C sugars in 619 
the replicative niche (and 5 C sugars if we assume that the evidence obtained in B. melitensis 620 
also applies to B. abortus; see Introduction). These sugars would provide trioses-phosphate 621 
through the pentose phosphate cycle and serve also as precursors for biosynthesis of envelope 622 
polymers. This second model, however, does not account for the attenuation observed for the 623 
ppdK and mae mutants, which strongly suggests that molecules necessary for growth are 624 
derived from the TCA in vivo.  625 
A third model proposes that there is a limited supply of 6 C (and 5 C) sugars that is 626 
compensated by glutamate, alanine and other amino acids. Those sugars would be used mostly 627 
or exclusively for biosynthesis of envelope polymers and for the pentose-phosphate cycle-628 
dependent biosynthetic reactions. This model is consistent with the results of this and previous 629 
works. First, the different phenotype of the B. abortus BABǻfbpǻglpx double mutant in vivo and 630 
in vitro is more coherent with the hypothesis that classical gluconeogenesis is not extensively 631 
used in vivo. In addition, the B. abortus 2308 gluP mutant identified in signature-tagged 632 
mutagenesis studies is not clearly attenuated at two weeks post-infection and manifests its 633 
attenuation at times (8 weeks) that correspond to the chronic phase (20). This suggests that the 634 
bacteria do not depend totally on hexoses for intracellular biosynthetic processes, and that this 635 
dependence is manifested at late times perhaps as the result of changes in the replicative 636 
vacuole (see below). Indeed, the infection experiments performed in alternatively activated 637 
macrophages suggest that, although available, glucose is a limiting factor for B. abortus growth 638 
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at least during the chronic phase (60). Proteomic studies carried out with B. abortus 2308 show 639 
that expression of two proteins of the dihydroxyacetone kinase complex (Dha) of the PEP-640 
carbohydrate phosphotransferase system (PTS) is reduced throughout infection in macrophages 641 
(23). Although this has been interpreted to mean that reduced PTS expression may be the result 642 
of a short supply of sugars within the replicative niche, the Brucella PTS lacks the sugar 643 
permease unit and is likely to act as a regulatory system coordinating C and N metabolism (61). 644 
On the other hand, the signature-tagged mutagenesis and proteomic studies show attenuation 645 
of a gltD (putatively encoding the small subunit of glutamate synthase) mutant (20) and an 646 
increment of enzymes involved in increasing the pool of glutamate (23) that are consistent with 647 
the model. Finally, this third model accounts for the attenuation of the ppdK and mae mutants 648 
and could also explain in part the differences between the mutants in these two genes that were 649 
observed in mice (Fig. 8). Since according to the model sugars are used mostly to construct 650 
envelope polymers and for pentose-phosphate cycle derived precursors, additional molecules 651 
for biosynthesis must be derived from TCA. PpdK works to produce PEP, which is used to 652 
synthesize phenylalanine, tyrosine and tryptophan, glycerolipids and other PEP-derived 653 
molecules. Mae supplies pyruvate for PpdK in vivo but TCA would not be the only source of 654 
pyruvate. This is suggested by the fact that the mae mutant was both delayed in reaching the 655 
chronic phase of infection and in lower numbers in the spleen during this phase, which contrasts 656 
with the inability of the ppdK mutant to generate chronic infections. Interestingly, it has been 657 
shown recently that, when provided with multiple carbon sources, Mycobacterium tuberculosis 658 
differentially catabolizes each carbon source through the glycolytic, pentose phosphate, and/or 659 
TCA pathways to distinct metabolic fates, and it has been suggested that this ability reflects an 660 
adaptation to pathogenicity (62). Indeed, such ability could also be necessary for B. abortus to 661 
coordinately use the different substrates proposed for this model.   662 
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Although the last model fits the experimental evidence, it is obvious that it represents only a 663 
first approach to the situation in the natural hosts because we cannot assume that the niche is 664 
static during a chronic infection or uniform among different types of cells. In the above-665 
mentioned signature-tagged mutagenesis studies, Hong et al. (20) have presented evidence for 666 
the hypothesis that different set of genes are required during the onset-acute phases and the 667 
chronic steady phase. This study identified three putative metabolic genes (gluP, glD [see 668 
above] and gcvP) required during the chronic phase but not markedly during the acute phase of 669 
infection. Indeed, both the need of a functional ppdK for the infection to progress during the 670 
acute phase and the different phenotype of mae add further support to the hypothesis that 671 
different genes are required to a different extent during the course of infection. Moreover, at 672 
least macrophages and trophoblastic cells have been clearly associated with B. abortus infection 673 
in cattle (63) and the physiological characteristics of these cells are different. Also, different 674 
spleen cells become colonized at different times after intraperitoneal inoculation of mice (64). 675 
Clearly, research is necessary to investigate these aspects of the relationship between 676 
metabolism and intracellular multiplication in B. abortus and in other species of the genus.  677 
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FIGURE LEGENDS 875 
FIG. 1. Conventional central metabolic pathways (glycolysis, gluconeogenesis, Entner-876 
Doudoroff, pentose-phosphate, TCA and glyxoylate) of bacteria. Dashed arrows indicate steps 877 
for which no putative genes can be identified in B. abortus. Red arrows indicate the steps 878 
studied in this work. Abbreviations used in the figure are: AcCoA (acetyl-CoA), AceA (isocitrate 879 
lyase), AceB (malate synthase), Acn (aconitate hidratase), AKG (Į-ketoglutarate), Akgdh (Į-880 
ketoglutarate dehydrogenase), Cgs (cyclic-glucan synthesis), CIT (citrate), DHAP 881 
(dihydroxyacetone phosphate), Eda (keto-deoxy-phosphogluconate aldolase), Edd (6-phospho-882 
D-gluconate dehydratase), E4P (erythrose-4-phosphate), Fba (fructose bisphosphate aldolase), 883 
Fbp (fructose-1,6-bisphosphatase), Fum (fumarase), FUM (fumarate), F1,6dP (fructose-1,6-884 
bisphosphate), F6P (fructose-6-phosphate), GalE (UPD-glucose-4 epimerase), GAP 885 
(glyceraldehyde-3-phosphate), Gnd (6-phosphogluconate dehydrogenase), Glk (glucokinase), 886 
GlpX (fructose-1,6-bisphosphatase), GltA (citrate synthase), GLX (glyoxylate), G1P (glucose-1-887 
phosphate), G6P (glucose-6-phosphate), ICIT (isocitrate), Idh (isocitrate dehydrogenase), KDPG 888 
(2-keto-3-deoxyphosphogluconate), LPS (lipopolysaccharide), Mae (malic enzyme), MAL 889 
(malate), Mdh (malate dehydrogenase), OAA (oxaloacetate), Pfk (phosphofructokinase), PckA 890 
(phosphoenol pyruvate carboxikinase), Pdh ( pyruvate dehydrogenase), PEP (phosphoenol 891 
pyruvate), Pgi (phosphoglucose isomerase), Pgl (lactonase), Pgm (phosphoglucomutase), Ppc 892 
(phosphoenol pyruvate carboxylase), PpdK (pyruvate phosphate dikinase), Pps (phosphoenol 893 
pyruvate synthase), Pyc  (pyruvate carboxylase), Pyk (pyruvate kinase), PYR (pyruvate), Pyrck 894 
(pyruvate carboxikinase), RIB5P (ribulose-5-phosphate), Sdh (succinate dehydrogenase), Stk 895 
(succinyl-CoA synthethase), SUC (succinate), SucCoA (succinyl-CoA), Tkt (transketolase), TpiA 896 
(triose phosphate isomerase), X5P (xylulose-5-phosphate), Zwf (glucose-6-phosphate 897 




FIG. 2. Growth curves in Peptone-Yeast Extract-Glucose (A.1, B.1 and C.1) and Glutamate-900 
Lactate-Glycerol (A.2, B.2 and C.2) of BAB-parental and mutants BAB¨fbp, BAB¨glpX, 901 
BAB¨fbp¨glpX, BAB¨pckA, BAB¨ppdK, BAB¨pckA¨ppdK and BAB¨mae. Each point 902 
represents the mean ± standard error (error bars are within the size of the symbols) of optical 903 
density (O.D.) values of triplicate samples. The experiment was repeated three times with similar 904 
results. 905 
 906 
FIG. 3. Growth curves in Glycerol-Glutamate, Glycerol-Lactate and Glutamate-Lactate of BAB-907 
parental and mutants BAB¨fbp, BAB¨glpX, BAB¨fbp¨glpX, BAB¨ppdK and BAB¨mae. Each 908 
point represents the mean of triplicate samples (error bars are within the size of the symbols). 909 
The experiment was repeated three times with similar results. 910 
 911 
FIG. 4. Immunofluorescence analysis of BAB-parental and BABǻfbpǻglpX grown in Glycerol-912 
Lactate-Glutamate. Cells were labeled with anti-smooth-lipopolysaccharide mouse monoclonal 913 
antibody A76/12G12/F12 and Alexa Fluor 546 conjugated goat anti-mouse immunoglobulin. 914 
 915 
FIG. 5. Luciferase expression under the control of B. abortus aceA promoter in Peptone-Yeast 916 
Extract-Glucose and Glutamate-Lactate-Glycerol. The results are representative of three 917 
experiments (RLU, relative luminescence units). 918 
 919 
FIG. 6. Intracellular multiplication in RAW 264.7 macrophages of BAB-parental and mutants 920 
BAB¨fbp¨glpX, BAB¨pckA, BAB¨ppdK, BAB¨pckA¨ppdK and BAB¨mae (virB is an attenuated 921 
mutant used as a control). Values are the mean ± standard error of triplicate infections and the 922 




FIG. 7. Trafficking of BAB-parental, BAB¨ppdK and virB in macrophages and HeLa cells. (A), 925 
confocal images of infected RAW 264.7 macrophages and HeLa cells labeled with Moabs to 926 
either calnexin (in green) or LAMP-1 (in blue) 24 hours after infection (bacteria are 927 
immunostained in red). (B), Percentage of calnexin-positive vacuoles of HeLa cells that contain 928 
bacteria at 24 and 48 hours post-infection. 929 
 930 
FIG. 8. Bacterial multiplication (upper panels) and spleen weights (lower panels) generated in 931 
BALB/c mice by BAB-parental and mutants BAB¨fbp¨glpX (A); BAB¨pckA, BAB¨ppdK and 932 
BAB¨pckA¨ppdK (B); and BAB¨mae (C). Each point is the mean ± standard deviation (n=5) of 933 
the Log of CFU or grams per spleen. Statistical differences with BAB-parental were significant (p 934 
< 0.001) from week 4 onwards for BAB¨ppdK and from week 2 onwards for BAB¨mae. 935 
BAB¨pckA¨ppdK was also attenuated at weeks 8 and 12 (p < 0.001) (weeks 4 and 6 were not 936 
tested). 937 








